Literature DB >> 29923041

Long-term health and socioeconomic consequences of childhood and adolescent onset of meningococcal meningitis.

Line Pickering1, Poul Jennum2, Rikke Ibsen3, Jakob Kjellberg4.   

Abstract

We estimated the long-term socioeconomic consequences and health care costs of Neisseria meningitidis meningitis (NM). The prospective cohort study included Danish individuals with onset of NM in childhood and adolescence, diagnosed between 1980 and 2009. Health care costs and socioeconomic data were obtained from nationwide administrative and health registers. Two thousand nine hundred two patients were compared with 11,610 controls matched for age, gender, and other sociodemographic characteristics. In the follow-up analysis at the age of 30 years, 1028 patients were compared with 4452 controls. We found that (1) NM caused increased mortality at disease onset, but after adequate treatment, the mortality rate was similar to that of the general population; (2) neurological and eye diseases were more frequently observed in patients; (3) patients had significantly lower grade-point averages; (4) patients had lower income even when transfer payments were taken into account; and (5) patients' initial health care costs were elevated.
Conclusion: NM has significant influence on mortality, morbidity, education, and income. We suggest that the management of patients with previous meningococcal meningitis should focus on early educational and social interventions to improve social and health outcomes. What is known: • Meningococcal meningitis is a severe infectious disease affecting children and adolescents with high rates of mortality and complications. What is new: • Meningococcal meningitis causes increased mortality at disease onset, but after adequate treatment the mortality rate is similar to that of the general population. • Meningococcal meningitis in childhood and adolescence has a major long-term effect on morbidity, health care costs, education, employment, and income.

Entities:  

Keywords:  Health; Meningitis; Morbidity; Mortality; Neisseria meningitidis; Socioeconomic

Mesh:

Year:  2018        PMID: 29923041     DOI: 10.1007/s00431-018-3192-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  18 in total

1.  Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.

Authors:  Lara J Wolfson; François Gasse; Shook-Pui Lee-Martin; Patrick Lydon; Ahmed Magan; Abdelmajid Tibouti; Benjamin Johns; Raymond Hutubessy; Peter Salama; Jean-Marie Okwo-Bele
Journal:  Bull World Health Organ       Date:  2008-01       Impact factor: 9.408

2.  Streptococcus suis meningitis in adults in Vietnam.

Authors:  Nguyen Thi Hoang Mai; Ngo Thi Hoa; Tran Vu Thieu Nga; Le Dieu Linh; Tran Thi Hong Chau; Dinh Xuan Sinh; Nguyen Hoan Phu; Ly Van Chuong; To Song Diep; James Campbell; Ho Dang Trung Nghia; Tran Ngoc Minh; Nguyen Van Vinh Chau; Menno D de Jong; Nguyen Tran Chinh; Tran Tinh Hien; Jeremy Farrar; Constance Schultsz
Journal:  Clin Infect Dis       Date:  2008-03-01       Impact factor: 9.079

3.  Morbidity, mortality and spatial distribution of meningococcal disease, 1974-2007.

Authors:  M Howitz; L Lambertsen; J B Simonsen; J J Christensen; K Mølbak
Journal:  Epidemiol Infect       Date:  2009-03-30       Impact factor: 2.451

4.  Morbidity of childhood onset narcolepsy: a controlled national study.

Authors:  Poul Jennum; Line Pickering; Eva Wiberg Thorstensen; Rikke Ibsen; Jakob Kjellberg
Journal:  Sleep Med       Date:  2016-11-03       Impact factor: 3.492

5.  Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study.

Authors:  Manish Sadarangani; David W Scheifele; Scott A Halperin; Wendy Vaudry; Nicole Le Saux; Raymond Tsang; Julie A Bettinger
Journal:  Clin Infect Dis       Date:  2015-01-20       Impact factor: 9.079

6.  Stroke in community-acquired bacterial meningitis: a Danish population-based study.

Authors:  Jacob Bodilsen; Michael Dalager-Pedersen; Henrik Carl Schønheyder; Henrik Nielsen
Journal:  Int J Infect Dis       Date:  2014-01-14       Impact factor: 3.623

7.  Health, social, and economic consequences of narcolepsy: a controlled national study evaluating the societal effect on patients and their partners.

Authors:  Poul Jennum; Rikke Ibsen; Eva Rosa Petersen; Stine Knudsen; Jakob Kjellberg
Journal:  Sleep Med       Date:  2012-07-25       Impact factor: 3.492

8.  Effect of socioeconomic position on survival after childhood cancer in Denmark.

Authors:  Sofie B Simony; Lasse W Lund; Friederike Erdmann; Klaus K Andersen; Jeanette F Winther; Joachim Schüz; Christoffer Johansen; Kjeld Schmiegelow; Susanne O Dalton
Journal:  Acta Oncol       Date:  2016-03-03       Impact factor: 4.089

9.  Neuroinfections in developed versus developing countries.

Authors:  Vladimír Krcméry; P G Fedor-Freybergh
Journal:  Neuro Endocrinol Lett       Date:  2007-06       Impact factor: 0.765

10.  Welfare cost of childhood- and adolescent-onset epilepsy: A controlled national study.

Authors:  Poul Jennum; Line Pickering; Jakob Christensen; Rikke Ibsen; Jakob Kjellberg
Journal:  Epilepsy Behav       Date:  2016-06-15       Impact factor: 2.937

View more
  3 in total

Review 1.  Non-corticosteroid adjuvant therapies for acute bacterial meningitis.

Authors:  Jane Fisher; Adam Linder; Maria Grazia Calevo; Peter Bentzer
Journal:  Cochrane Database Syst Rev       Date:  2021-11-23

Review 2.  Neurocognitive and functional impairment in adult and paediatric tuberculous meningitis.

Authors:  Suzanne T Anderson; Felicia C Chow; Angharad G Davis; Sam Nightingale; Priscilla E Springer; Regan Solomons; Ana Arenivas; Robert J Wilkinson
Journal:  Wellcome Open Res       Date:  2019-11-13

3.  Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease-Real-World Data Analysis Using the French National Claims Database (SNIIRAM).

Authors:  Jing Shen; Stéphane Bouée; Emmanuel Aris; Corinne Emery; Ekkehard C Beck
Journal:  Infect Dis Ther       Date:  2021-11-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.